H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell components-Reference-Cited by-同舟云学术

H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell components

Published:2019-05-20 Issue:1 Volume:7 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Andreiuolo Felipe^ORCID,Lisner Tomo,Zlocha Jozef,Kramm Christof,Koch Arend,Bison Brigitte,Gareton Albane,Zanello Marc,Waha Andreas,Varlet Pascale,Pietsch Torsten

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-019-0731-5.pdf

Reference13 articles.

1. Bjerke L, Mackay A, Nandhabalan M et al (2013) Histone H3.3 mutations drive paediatric glioblastoma through upregulation of MYCN. Cancer Discov 3(5):512–519

2. Gessi M, Gielen GH, Hammes J et al (2013) H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications. J Neuro-Oncol 112(1):67–72

3. Grill J, Massimino M, Bouffet E et al (2018) Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma. J Clin Oncol 36(10):951–958

4. Haque F, Varlet P, Puntonet J et al (2017) Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours. Acta Neuropathol Commun 5(1):45

5. Hoischen A, Ehrler M, Fassunke J et al (2008) Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH. Brain Pathol 18(3):326–337

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare Pathogenic Variants Identified in Whole Exome Sequencing of Monozygotic Twins With Autism Spectrum Disorder;Pediatric Neurology;2024-09

2. Molecular and Pathological Features of Paediatric High-Grade Gliomas;International Journal of Molecular Sciences;2024-08-03

3. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?;Frontiers in Molecular Neuroscience;2024-03-13

4. Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review;Journal of Neuro-Oncology;2024-03

5. H3G34-Mutant Gliomas—A Review of Molecular Pathogenesis and Therapeutic Options;Biomedicines;2023-07-15